AcquirerTargetPrice
OptumRxAlexaCare Holdings, Inc. N/A
Charles River LaboratoriesOncotest GmbH$36 million
CONMED CorporationSuriQuest, Inc. $265 million
ams AGCMOSIS$235 million
Depomed Inc. Depomed Inc.
Rights to cebranopadol
N/A